You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

malignant solid tumor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor Trial (SHR-4602 for injection)

Not yet recruiting
  • Advanced Solid Tumor
  • SHR-4602 for injection
  • (no location specified)
Apr 6, 2023

HER2-positive Recurrent or Metastatic Malignant Solid Tumor Trial in Zhengzhou (Recombinant Humanized Bispecific Monoclonal

Recruiting
  • HER2-positive Recurrent or Metastatic Malignant Solid Tumor
  • Recombinant Humanized Bispecific Monoclonal Antibody MBS301
  • Zhengzhou, China
    Henan Cancer Hospital
Nov 9, 2022

Advanced Solid Tumor Trial in Xuzhou (Oncolytic Virus Injection(Revottack)+PD-1)

Not yet recruiting
  • Advanced Solid Tumor
  • Oncolytic Virus Injection（Revottack）+PD-1
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Dec 1, 2022

Cutaneous Tumor, Malignant Solid Tumor Trial (JCXH-211 Injection)

Not yet recruiting
  • Cutaneous Tumor
  • Malignant Solid Tumor
  • JCXH-211 Injection
  • (no location specified)
Feb 13, 2023

Advanced Malignant Solid Tumors Trial in Shanghai (HMPL-415S1)

Not yet recruiting
  • Advanced Malignant Solid Tumors
  • Shanghai, Shanghai, China
    Zhongshan Hospital Fudan University
May 23, 2023

Malignant Solid Tumor Trial in Shanghai (Infusion of iNKT cells)

Completed
  • Malignant Solid Tumor
  • Infusion of iNKT cells
  • Shanghai, China
    Shanghai Public Health Clinical Center, Fudan University
May 6, 2022

Malignant Solid Tumor Trial (GEN1042, Pembrolizumab, Cisplatin)

Not yet recruiting
  • Malignant Solid Tumor
  • GEN1042
  • +4 more
  • (no location specified)
Sep 21, 2023

Advanced Malignant Solid Tumor Trial in Huntersville (BNT314, Pembrolizumab)

Not yet recruiting
  • Advanced Malignant Solid Tumor
  • BNT314
  • Pembrolizumab
  • Huntersville, North Carolina
    Carolina BioOncology Institute, LLC
Nov 21, 2023

Cutaneous Tumor, Malignant Solid Tumor Trial in Houston (JCXH-211)

Not yet recruiting
  • Cutaneous Tumor
  • Malignant Solid Tumor
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Sep 9, 2022

Advanced Malignant Solid Tumor Trial in Hangzhou (9MW3811 Injection)

Not yet recruiting
  • Advanced Malignant Solid Tumor
  • 9MW3811 Injection
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Jun 12, 2023

Non-squamous NSCLC, Epithelial Ovarian Cancer Trial (AMG 794)

Not yet recruiting
  • Non-squamous Non-small Cell Lung Cancer
  • Epithelial Ovarian Cancer
  • AMG 794
  • Orange, California
    University of California at Irvine
Jan 25, 2023

Malignant Solid Tumor Trial in Hackensack, New York, Spokane (ZL-1218, Pembrolizumab)

Recruiting
  • Malignant Solid Tumor
  • Hackensack, New Jersey
  • +2 more
May 4, 2023

Refractory Solid Tumor, Hepatocellular Carcinoma, Malignant Solid Tumor Trial in Memphis (Atezolizumab, Sorafenib, Bevacizumab)

Recruiting
  • Refractory Solid Tumor
  • +4 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 4, 2022

Malignant Solid Tumor Trial in Nashville (Ifetroban Sodium, Placebo)

Recruiting
  • Malignant Solid Tumor
  • Ifetroban Sodium
  • Placebo
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Jun 23, 2022

Advanced Malignant Solid Tumor Trial in Jinan, Shanghai (IAE0972)

Not yet recruiting
  • Advanced Malignant Solid Tumor
  • Jinan, Shandong, China
  • +1 more
May 24, 2022

Solid Tumor Trial in Beijing (JK-1201I)

Completed
  • Solid Tumor
  • Beijing, Beijing, China
    The fifth medical center of PLA general hospital
Nov 16, 2021

Advanced Malignant Solid Tumor Trial in Hangzhou (Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1 Injection)

Not yet recruiting
  • Advanced Malignant Solid Tumor
  • Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1 Injection
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital，Zhejiang University School of Medi
Jul 25, 2022

Advanced Malignant Solid Tumors Trial in Nanchang (Neoantigen peptide vaccine, Neoantigen-based DC immune preparation)

Not yet recruiting
  • Advanced Malignant Solid Tumors
  • Neoantigen peptide vaccine
  • Neoantigen-based DC immune preparation
  • Nanchang, Jiangxi, China
    First Affiliated Hospital of Nanchang University
Mar 1, 2023

Advanced Solid Tumor, Stereotactic Body Radiotherapy, Immune Checkpoint Inhibitor Trial in Peking (Cadonilimab, Stereotactic

Not yet recruiting
  • Advanced Solid Tumor
  • +4 more
  • Peking, Beijing, China
    Department of radiation oncology, Peking University Third Hospit
Jun 20, 2023

Carcinoma, Solid Tumor Trial in Suzhou (ADC Combined With Radiotherapy, PD-L1 Sequential GM-CSF and Thymopentin)

Not yet recruiting
  • Carcinoma
  • Solid Tumor
  • ADC Combined With Radiotherapy, PD-L1 Sequential GM-CSF and Thymopentin
  • Suzhou, China
    Second Affiliated Hospital of Soochow University
Oct 26, 2023

Digestive System Malignant Solid Tumors Trial (ScTIL injection, ScTIL injection and B lymphocytes adjuvant)

Not yet recruiting
  • Digestive System Malignant Solid Tumors
  • ScTIL injection
  • ScTIL injection and B lymphocytes adjuvant
  • (no location specified)
Feb 7, 2023

Solid Tumor Trial (UCLM802 Cell Injection)

Not yet recruiting
  • Solid Tumor
  • UCLM802 Cell Injection
  • (no location specified)
Mar 7, 2023

Tumor Infiltrating Lymphocytes, Safety, Advanced Solid Tumor Trial in Beijing (TIL therapy)

Recruiting
  • Tumor Infiltrating Lymphocytes
  • +5 more
  • TIL therapy
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Dec 19, 2022

Advanced Malignant Solid Tumor Trial in France, Netherlands (MP0317, a tri-specific fibroblast activation protein (FAP) x CD40

Recruiting
  • Advanced Malignant Solid Tumor
  • MP0317, a tri-specific fibroblast activation protein (FAP) x CD40 DARPin® drug candidate
  • Lyon, Cedex 08, France
  • +3 more
Nov 4, 2022

Advanced Malignant Tumor Trial (HRS-2189 Tablets)

Not yet recruiting
  • Advanced Malignant Tumor
  • HRS-2189 Tablets
  • (no location specified)
May 6, 2023